AGL agilon health, inc.
Services-Misc Health & Allied Services, NEC · NYSE · SEC CIK 1831097 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.52B | $1.49B | $1.42B | $1.57B | $1.44B | $1.39B | $1.53B | $1.52B |
| SG&A expense | $67.13M | $88.50M | $54.23M | $60.10M | $56.20M | $56.28M | $65.96M | $59.76M |
| Operating income | $24.11M | $11.77M | $4.00M | -$193.82M | -$131.27M | -$116.03M | -$22.11M | -$108.10M |
| Interest expense | $1.74M | $1.61M | $1.81M | $1.72M | $1.84M | $1.57M | $1.51M | $1.57M |
| Pretax income | $38.91M | $17.58M | $29.94M | -$187.56M | -$110.54M | -$104.31M | -$1.69M | -$104.67M |
| Income tax | $4.00M | -$375,000 | $28,000 | $1.32M | -$331,000 | $62,000 | $196,000 | $1.76M |
| Net income | $34.91M | $17.96M | $48.92M | -$188.88M | -$110.21M | -$104.37M | $12.11M | -$105.79M |
| EBITDA | $30.85M | $18.63M | $10.78M | -$186.86M | -$123.84M | -$108.71M | -$15.23M | -$101.61M |
| EPS (basic) | 2.08 | 1.07 | 2.95 | — | -6.65 | -6.31 | 0.73 | — |
| EPS (diluted) | 1.97 | 1.04 | 2.94 | — | -6.65 | -6.31 | 0.73 | — |
| Weighted avg. shares (diluted) | 17.69M | 17.21M | 16.66M | — | 16.58M | 16.55M | 16.52M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $174.40M | $107.18M | $139.99M | $173.71M | $171.68M | $171.42M | $136.94M | $188.23M |
| Receivables | $1.02B | $1.06B | $899.75M | $673.79M | $947.16M | $1.05B | $1.24B | $1.02B |
| Current assets | $1.40B | $1.42B | $1.32B | $1.10B | $1.34B | $1.45B | $1.65B | $1.46B |
| PP&E, net | $24.04M | $24.51M | $24.89M | $25.42M | $26.15M | $27.41M | $28.09M | $28.17M |
| Goodwill | — | — | — | $0 | $24.13M | $24.13M | $24.13M | $24.13M |
| Intangibles | $56.85M | $60.13M | $62.45M | $65.72M | $75.25M | $65.59M | $68.19M | $72.77M |
| Total assets | $1.57B | $1.59B | $1.50B | $1.27B | $1.60B | $1.71B | $1.93B | $1.73B |
| Current liabilities | $1.23B | $1.31B | $1.27B | $1.08B | $1.24B | $1.25B | $1.37B | $1.15B |
| Short-term debt | $15.02M | $14.91M | $14.75M | $19.24M | $34.97M | $34.95M | $34.92M | $0 |
| Long-term debt | $15.51M | $15.38M | $15.28M | $15.75M | $0 | $0 | $0 | $34.90M |
| Total debt | $30.53M | $30.29M | $30.02M | $34.99M | $34.97M | $34.95M | $34.92M | $34.90M |
| Total liabilities | $1.28B | $1.36B | $1.32B | $1.14B | $1.29B | $1.30B | $1.43B | $1.26B |
| Shareholders' equity | $280.88M | $227.53M | $181.43M | $126.73M | $306.08M | $408.93M | $500.25M | $470.95M |
| Net debt | -$143.87M | -$76.89M | -$109.96M | -$138.72M | -$136.72M | -$136.47M | -$102.02M | -$153.33M |
| Shares outstanding | 16.80M | 16.79M | 16.61M | 16.59M | 414.57M | 414.28M | 413.02M | 412.19M |
| Cash flow statement | ||||||||
| Operating cash flow | $49.87M | -$57.30M | $23.73M | -$20.54M | -$18.15M | -$35.09M | -$31.99M | $16.42M |
| Capital expenditure | $3.26M | $3.45M | $3.10M | $2.97M | $3.17M | $3.25M | $3.85M | $3.27M |
| Free cash flow | $46.62M | -$60.74M | $20.63M | -$23.50M | -$21.33M | -$38.34M | -$35.84M | $13.15M |
| Investing cash flow | $17.82M | $19.91M | $19.27M | $22.58M | $18.66M | $70.46M | -$23.09M | $23.67M |
| Financing cash flow | -$124,000 | $4.63M | -$5.15M | -$17,000 | -$236,000 | -$2.58M | -$161,000 | -$22,000 |
| Depreciation & amortization | $6.74M | $6.86M | $6.79M | $6.97M | $7.43M | $7.32M | $6.88M | $6.49M |
| Stock-based compensation | $18.86M | $23.83M | $6.25M | $9.52M | $7.50M | $15.38M | $16.72M | $2.28M |
Free plan shows the latest 8 periods; Pro shows all 27 🔒
· This company does not report gross profit in XBRL.
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.